GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (HKSE:09688) » Definitions » Accumulated other comprehensive income (loss)

Zai Lab (HKSE:09688) Accumulated other comprehensive income (loss) : HK$294 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Zai Lab Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Zai Lab's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was HK$294 Mil.

Zai Lab's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 (HK$409 Mil) to Sep. 2023 (HK$375 Mil) and declined from Sep. 2023 (HK$375 Mil) to Dec. 2023 (HK$294 Mil).

Zai Lab's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 (HK$-184 Mil) to Dec. 2022 (HK$200 Mil) and increased from Dec. 2022 (HK$200 Mil) to Dec. 2023 (HK$294 Mil).

Zai Lab Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Zai Lab's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab Accumulated other comprehensive income (loss) Chart

Zai Lab Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only 36.06 -112.59 -184.41 199.97 293.85

Zai Lab Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 199.97 135.56 408.73 375.39 293.85

Zai Lab Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Zai Lab Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Zai Lab's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zai Lab (HKSE:09688) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (HKSE:09688) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
MLTX RARE DNLI ARWR MDGL DNA FTRE CORT AXSM TRML OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ZLAB:USA ZLAB:Mexico 1ZLB:Germany
Address
4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210
Website
https://www.zailaboratory.com
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Zai Lab (HKSE:09688) Headlines

No Headlines